drugs
|
specialties
|
general news
|
education
UnregisterUser
Indonesia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Others Services
Indonesia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
drugs
|
specialties
|
general news
|
education
UnregisterUser
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
MIMS home
Drugs
Info
Midric
Midric
tropicamide
Produsen:
Sanbe Vision
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Bahasa Concise Prescribing Info
Komposisi
Tropicamide.
Indikasi/Kegunaan
Midriasis & sikloplegia utk prosedur diagnostik.
Dosis/Cara Penggunaan
Dws
2 tetes diulang dlm 5 mnt. Jika diperlukan berikan 1-2 tetes ssdh 30 mnt.
Anak
sesuai dengan anjuran dokter.
Kontraindikasi
Glaukoma primer atau kecenderungan utk mengalami glaukoma. Menggunakan lensa kontak.
Perhatian Khusus
Dpt mengganggu kemampuan mengemudi atau menjalankan mesin. Hindari mata selama dilatasi dari cahaya terang. Bayi, anak & lansia.
Efek Samping
Peningkatan TIO, reaksi psikotik, ggn perilaku, kolaps kardiorespirasi pd anak & dws; rasa tersengat (sementara), mulut kering, penglihatan kabur, fotofobia, takikardi, sakit kepala, stimulasi parasimpatik, reaksi alergi.
View
ADR Monitoring Form
Interaksi Obat
Amantadin, antihistamin, butirofenon, fenotiazin & antidepresan trisiklik.
Klasifikasi MIMS
Obat Midriatikum
Klasifikasi Kimiawi Terapeutik Anatomis
S01FA06 - tropicamide ; Belongs to the class of anticholinergics used as mydriatics and cycloplegics.
Klasifikasi menurut Peraturan
G
Bentuk Sediaan/Kemasan
Form
Midric tetes mata 5 mg/mL
Packing/Price
5 mL x 1's (Rp28,100/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member?
Sign in